Condition
Docetaxel clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Docetaxel clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Gemcitabine, Docetaxel, Melphalan, and Carboplatin with a Second Transplant in Young Patients with Relapsed Germ Cell Tumors
This study tests whether a tandem autologous stem cell transplant with GemDMC, followed by CE, can help children and teens with relapsed or refractory germ cell tumors.
-
Comparing oxaliplatin plus S-1 versus docetaxel plus S-1 after surgery for stage III stomach cancer
This trial tests whether oxaliplatin plus S-1 or docetaxel plus S-1 is better at preventing cancer recurrence in people with stage III gastric cancer after D2 gastrectomy.
Related topics
Quick answers
How many Docetaxel clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.